En Carta Diagnostics - Crunchbase Company Profile & Funding

Q: Who invested in En Carta Diagnostics?

En Carta Diagnostics is funded by CentraleSupélec Venture.

Q: How much funding has En Carta Diagnostics raised to date?

En Carta Diagnostics has raised obfuscated.

Overview

En Carta Diagnostics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About En Carta Diagnostics

CB Rank

28280

En Carta Diagnostics is a state-of-the-art molecular testing platform.

Founded

obfuscation

Private

Pre-Seed

Paris, Ile-de-France, France

1-10

www.encarta.bio/

Biotechnology

Health Diagnostics

Medical Device

Funding Rounds

Pre-Seed

OBF

obfuscation

Details

Legal Name

EN CARTA DIAGNOSTICS SAS

Also Known As

En Carta, encarta bio

Operating Status

Active

Company Type

For Profit

About the Company

En Carta Diagnostics is a state-of-the-art molecular testing platform that focuses on development of healthcare molecular diagnostics tools from the field of synthetic biology.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Molecular Diagnostic Platform

A platform that detects the genetic code of pathogens with PCR-level precision using simple tests operable via smartphone without specialized equipment or healthcare professionals.

Early Lyme Disease Diagnostic Test

A test that detects Lyme disease infection directly at the tick bite site to enable early intervention and prevent disease progression.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Pre Seed Round - En Carta Diagnostics	1	obfuscated obfuscation	CentraleSupélec Venture	Pre-Seed
obfuscated obfuscation	Pre Seed Round - En Carta Diagnostics	1	obfuscated obfuscation	CentraleSupélec Venture	Pre-Seed
obfuscated obfuscation	Pre Seed Round - En Carta Diagnostics	1	obfuscated obfuscation	CentraleSupélec Venture	Pre-Seed
obfuscated obfuscation	Pre Seed Round - En Carta Diagnostics	1	obfuscated obfuscation	CentraleSupélec Venture	Pre-Seed
obfuscated obfuscation	Pre Seed Round - En Carta Diagnostics	1	obfuscated obfuscation	CentraleSupélec Venture	Pre-Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Pre Seed Round - En Carta Diagnostics	1	obfuscated obfuscation	CentraleSupélec Venture	Pre-Seed
obfuscated obfuscation	Pre Seed Round - En Carta Diagnostics	1	obfuscated obfuscation	CentraleSupélec Venture	Pre-Seed
obfuscated obfuscation	Pre Seed Round - En Carta Diagnostics	1	obfuscated obfuscation	CentraleSupélec Venture	Pre-Seed
obfuscated obfuscation	Pre Seed Round - En Carta Diagnostics	1	obfuscated obfuscation	CentraleSupélec Venture	Pre-Seed
obfuscated obfuscation	Pre Seed Round - En Carta Diagnostics	1	obfuscated obfuscation	CentraleSupélec Venture	Pre-Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
CentraleSupélec Venture	Yes	Pre Seed Round - En Carta Diagnostics	Cédric Curtil
CentraleSupélec Venture	Yes	Pre Seed Round - En Carta Diagnostics	Cédric Curtil
CentraleSupélec Venture	Yes	Pre Seed Round - En Carta Diagnostics	Cédric Curtil
CentraleSupélec Venture	Yes	Pre Seed Round - En Carta Diagnostics	Cédric Curtil
CentraleSupélec Venture	Yes	Pre Seed Round - En Carta Diagnostics	Cédric Curtil